AR012187A1 - LACTOSE FREE PHARMACEUTICAL COMPOSITION CONTAINING NORATEMIZOL AS AN ACTIVE AGENT, DOSAGE FORMS CONTAINING SUCH COMPOSITION AND METHOD FOR THE TREATMENT OF ALLERGIC DISORDERS WITH APPLICATION OF SUCH COMPOSITION - Google Patents

LACTOSE FREE PHARMACEUTICAL COMPOSITION CONTAINING NORATEMIZOL AS AN ACTIVE AGENT, DOSAGE FORMS CONTAINING SUCH COMPOSITION AND METHOD FOR THE TREATMENT OF ALLERGIC DISORDERS WITH APPLICATION OF SUCH COMPOSITION

Info

Publication number
AR012187A1
AR012187A1 ARP980101398A ARP980101398A AR012187A1 AR 012187 A1 AR012187 A1 AR 012187A1 AR P980101398 A ARP980101398 A AR P980101398A AR P980101398 A ARP980101398 A AR P980101398A AR 012187 A1 AR012187 A1 AR 012187A1
Authority
AR
Argentina
Prior art keywords
composition
treatment
noratemizol
active agent
dosage forms
Prior art date
Application number
ARP980101398A
Other languages
Spanish (es)
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AR012187A1 publication Critical patent/AR012187A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se trata de composiciones farmacéuticas, química y térmicamente estables, formuladas con un potente antihistamínico de formula I denominado norastemizol.Dichas composicones están exentas de lactosa, no son higroscopicas, y se presentan en forma anhidra, en partículas grandes o recubiertas, denorastemizol o sales farmacéuticamente aceptables del mismo, de simple fabricacion. También se proponen métodos para el tratamiento de estadosalérgicos.These are pharmaceutical compositions, chemically and thermally stable, formulated with a powerful antihistamine of formula I called norastemizole. These compositions are free of lactose, are not hygroscopic, and present in anhydrous form, in large or coated particles, denorastemizole or pharmaceutically salts acceptable thereof, of simple manufacture. Methods for the treatment of allergic states are also proposed.

ARP980101398A 1997-03-26 1998-03-26 LACTOSE FREE PHARMACEUTICAL COMPOSITION CONTAINING NORATEMIZOL AS AN ACTIVE AGENT, DOSAGE FORMS CONTAINING SUCH COMPOSITION AND METHOD FOR THE TREATMENT OF ALLERGIC DISORDERS WITH APPLICATION OF SUCH COMPOSITION AR012187A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82447797A 1997-03-26 1997-03-26
US85178697A 1997-05-06 1997-05-06

Publications (1)

Publication Number Publication Date
AR012187A1 true AR012187A1 (en) 2000-09-27

Family

ID=27124816

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101398A AR012187A1 (en) 1997-03-26 1998-03-26 LACTOSE FREE PHARMACEUTICAL COMPOSITION CONTAINING NORATEMIZOL AS AN ACTIVE AGENT, DOSAGE FORMS CONTAINING SUCH COMPOSITION AND METHOD FOR THE TREATMENT OF ALLERGIC DISORDERS WITH APPLICATION OF SUCH COMPOSITION

Country Status (13)

Country Link
EP (1) EP1035869A1 (en)
JP (1) JP2002512614A (en)
KR (1) KR20010005746A (en)
CN (1) CN1257431A (en)
AR (1) AR012187A1 (en)
BR (1) BR9808428A (en)
CA (1) CA2284705A1 (en)
HU (1) HUP0001823A3 (en)
NO (1) NO994655L (en)
NZ (3) NZ517472A (en)
RU (1) RU2214245C2 (en)
WO (1) WO1998042379A2 (en)
ZA (1) ZA982562B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ289261B6 (en) 2000-07-11 2001-12-12 Léčiva, A.S. Tablet that can be produced by direct tabletting, containing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active compound and process for producing thereof
EP2201982A1 (en) * 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
EA201270309A1 (en) * 2009-08-24 2012-07-30 Абды Ибрахым Иладж Санайи Ве Тыджарет Аноным Сыркеты OTILONIA TABLETS RECEIVED BY DIRECT PRESSING

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3781173T2 (en) * 1986-02-03 1992-12-17 Janssen Pharmaceutica Nv ANTI-HISTAMINIC COMPOSITIONS CONTAINING N-HETEROCYCLIC-4-PIPERIDINAMINE.
DE4037426A1 (en) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh PIPERIDINOALKYLBENZAZAZIN- AND -THIAZIN COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF AND THE COMPOSITIONS CONTAINING SUCH COMPOUNDS
DE4394931T1 (en) * 1992-09-03 1995-07-20 Sepracor Inc Use of norastemizole for the treatment of allergic diseases
PT920425E (en) * 1995-11-17 2003-07-31 Aventis Pharma Inc 4- (1H-BENZIMIDAZOL-2-YL-AMINO) USED SUBSTITUTED PIPERIDINES FOR THE TREATMENT OF ALLERGIC DISEASES
EP0920315B1 (en) * 1996-08-16 2005-12-28 Schering Corporation Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Also Published As

Publication number Publication date
HUP0001823A3 (en) 2002-04-29
RU2214245C2 (en) 2003-10-20
WO1998042379A3 (en) 2001-03-01
NO994655D0 (en) 1999-09-24
CN1257431A (en) 2000-06-21
ZA982562B (en) 1998-10-01
NZ517472A (en) 2003-08-29
HUP0001823A2 (en) 2001-04-28
AU6868098A (en) 1998-10-20
EP1035869A1 (en) 2000-09-20
BR9808428A (en) 2000-05-23
CA2284705A1 (en) 1998-10-01
NO994655L (en) 1999-11-15
AU735257B2 (en) 2001-07-05
NZ527200A (en) 2004-12-24
KR20010005746A (en) 2001-01-15
JP2002512614A (en) 2002-04-23
NZ527201A (en) 2004-12-24
WO1998042379A2 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
AR018109A1 (en) ADMINISTRABLE GALENIC FORMULATION BY ORAL ROUTE THAT ALLOWS AN IMPROVED ABSORPTION OF ACTIVE PRINCIPLES, USE OF AN ABSORPTION MAJORATING AGENT TO PREPARE AN ADMINISTRABLE DOSAGE METHOD BY ORAL ROUTE AND PROCEDURE TO PREPARE THE GINAL FORMULA
AR046933A1 (en) EFFECTIVENESS OF IMPROVED HUMECTATION THROUGH THE USE OF HYDROXIALQUILUREA
GT199900203A (en) CELECOXIB COMPOSITIONS.
CY1107925T1 (en) SOLUTION FOR Nail application
CL2008002407A1 (en) Oral dosage form comprising at least one nicotine active agent, at least one bioadhesive material capable of forming a hydrogen bond with the nicotine active agent, and at least one rapidly releasing sensory impact agent; and its use to provide rapid relief from nicotine cravings (div. sol. 1825-04).
BRPI0513864A (en) compounds, process for their manufacture, pharmaceutical compositions comprising them, their use and method for the treatment and / or prophylaxis of diseases
MX9202407A (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ALYLAMINE COMPOUND AS THE ACTIVE AGENT AND PROCESS FOR ITS PREPARATION.
SE0102438D0 (en) New compounds
AR053541A1 (en) COMBINATION OF XOLAIR WITH IMMUNOSUPPRESSING AGENT
CO4440476A1 (en) SYNERGISTIC COMPOSITION THAT INCLUDES A PESTICIDE COMBINATION OF ACTIVE INGREDIENTS.
AR034900A1 (en) USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT
FI964285A (en) Pharmaceutical preparations based on derivatives belonging to the taxane class
ATE287267T1 (en) COMBINATION THERAPIES WITH VASCULAR DAMAGE ACTIVITY
ECSP034826A (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE
SE9802208D0 (en) Novel compounds
BR9809022A (en) Topical nasal anti-inflammatory compositions
AR029456A1 (en) SHREDDED FORM
FR2816507B1 (en) MICROGRANULES BASED ON ACTIVE PRINCIPLE, PROCESS FOR THE MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAID MICROGRANULES
BR0306732A (en) Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound
DK1280558T3 (en) Semi-solid administration vehicle and pharmaceutical compositions
AR012187A1 (en) LACTOSE FREE PHARMACEUTICAL COMPOSITION CONTAINING NORATEMIZOL AS AN ACTIVE AGENT, DOSAGE FORMS CONTAINING SUCH COMPOSITION AND METHOD FOR THE TREATMENT OF ALLERGIC DISORDERS WITH APPLICATION OF SUCH COMPOSITION
DE69919597D1 (en) TOPICAL FORMULATIONS CONTAINING SKIN PENETRATION AGENTS AND THEIR USE
ES2150404T3 (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITOZOXANIDA.
CO5261624A1 (en) NEW FENILHETEROALQUILAMINE DERIVATIVES, PROCESSES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH NEW NOVEDOUS DERIVATIVES AND THEIR USE IN THERAPY
SE0000303D0 (en) Novel compounds

Legal Events

Date Code Title Description
FB Suspension of granting procedure